SELICK HAROLD E sold 28.3% of their position (24K shares) of PROTAGONIST THERAPEUTICS, INC on the open market
Open‑market sale worth $2.52M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/27/2026ACC: 0001104659-26-036318
Director
Since Apr 2019
-24K
Net shares
Net seller
$2.52M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
24K acquired · 48K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+24K
Price / share
$12.88
Trade value
$309.12K
% of position
39.4%
3/26/2026
60.84K→84.84K
Common Stock
Direct
Shares
−24K
Price / share
$105.00
Trade value
$2.52M
% of position
28.3%
3/26/2026
84.84K→60.84K
Total
Net shares
+0.00
Net value
-$2.21M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/26/2026 | M · Option Exercise | +24K | $12.88 | $309.12K | 39.4% | 60.84K | 84.84K |
| Common Stock Direct | 3/26/2026 | S · Sale | −24K | $105.00 | $2.52M | 28.3% | 84.84K | 60.84K |
| Total | +0.00 | -$2.21M | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
24K shares
Shares
−24K
Strike price
12.88
Held after
0.00
Exercisable
—
3/26/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock24K shares | 3/26/2026 | M · Option Exercise | −24K | 12.88 | — | 0.00 |